At2g29320 Antibody

Basic Research Questions

How to validate antibody specificity for At2g29320 in complex biological samples?

• Perform orthogonal validation using CRISPR-Cas9 knockout (KO) cell lines as negative controls in Western blotting and immunofluorescence .

• Combine multiple techniques:

  • Immunoprecipitation-MS: Verify co-precipitation of At2g29320

  • Concentration-response curves: Establish linear dynamic range in ELISA (e.g., EC₅₀ determination as in )

  • Cross-reactivity screening: Use protein arrays containing homologs from Arabidopsis thaliana proteome

What experimental controls are essential when studying At2g29320 function?

How to optimize antibody concentration for different applications?

• Prioritize concentrations achieving >90% maximal signal with <15% cross-reactivity .

Advanced Research Questions

How to resolve contradictory results between immunolocalization and Western blot data?

• Epitope analysis: Map antibody binding regions using peptide arrays

• Post-translational modification (PTM) assessment: Compare results from:

  • PTM-enriched vs. PTM-depleted samples

  • Lambda phosphatase-treated lysates

• Quantitative correlation: Calculate Pearson’s r between IF intensity and WB band density across 10+ biological replicates

What computational strategies enhance antibody validation for At2g29320?

• Integrate multi-omics data:

  Data Type	Validation Insight	Source
  RNA-seq	Confirm target expression in test systems
  Structural modeling	Predict antibody-antigen docking (e.g., GaluxDesign)
  Pathway analysis	Verify expected biological context (e.g., COPI transport)

How to address batch-to-batch variability in long-term studies?

• Implement:

  • Reference standard calibration: Preserve aliquots from initial characterization

  • Accelerated stability testing:

    • 4°C (1 month) vs. -80°C (baseline) storage comparisons

  • Inter-lab validation: Coordinate round-robin testing across 3+ facilities

Methodological Insights from Recent Studies

• Antibody performance metrics ( ):

  Parameter	GX-aPDL1-2	Commercial Reference
  KD (nM)	2.1 ± 0.3	1.9 ± 0.2
  Titer (mg/L)	420	150
  Monomericity (%)	98.7	97.5

• Pathway enrichment analysis ( ):
  At2g29320-associated antibodies showed significant enrichment in:

  • Vesicle-mediated transport (p=3.2e-5)

  • Rho-GTPase signaling (p=1.8e-4)

  • Lipid metabolism (p=4.6e-3)